Funds would prefer to take a large holding in BYE but OEL is undervalued, it's a buy when whoever is selling is finished. Looks to have a heap left.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025